The worldwide incidence of non-melanoma skin cancer (NMSC) has risen dramatically over the last decades. Basal cell carcinoma (BCC) is by far the most common type of skin cancer. NMSC needs to be regarded as a chronic disease that has enormous implications for health care systems, as will be outlined in this thesis. Physicians will need to take these implications, including costs, into account.
Simone van der Geer-Rutten
Contact Us
DermRay helps dermatology practices leverage the benefits of Xstrahl’s dual modality Radiant system to expand treatment options for NMSC. For more than a decade, radiation oncologists Ankit Agarwal, MD and David Greene, MD, at DermRay have been providing turnkey...
La radioterapia superficial y de ortovoltaje proporciona una opción de tratamiento eficaz para una amplia variedad de indicaciones médicas, incluidos el cáncer de piel no melanoma, algunas afecciones benignas e incluso cuidados paliativos. Únase a Xstrahl y al...
The role of radiation in treating non-malignant diseases is currently undergoing an American Renaissance. Low-dose radiation therapy (LDRT) has been used successfully throughout the world for treating benign conditions for over a century, but its resurgence has been...
